Extracellular vesicles (EV) are typically classified as small EV (sEV or exosome, with a diameter of approximately 50--150 nm) or large EV (or microvesicles, with a diameter of approximately 50 nm--1 *µ*m) \[[@r24]\]. EV consist of a lipid-bilayered membrane and contain various molecules, including proteins, DNA, microRNA, lipids, and metabolites \[[@r2], [@r20]\]. sEV are arisen from endosomal compartments called multivesicular bodies (MVBs). During the biogenesis of sEV, the membrane of MVBs invaginates inward forming intraluminal vesicles (ILVs). Fusion of the MVBs with the plasma membrane mediates the release of ILVs into the extracellular fluid, which are then referred as sEV \[[@r2]\]. The circulating sEV are mostly uptaken by the tissues where blood vessels are distributed \[[@r8]\] and they do not seem to be excreted through the urine \[[@r19]\]. The released sEV affect cellular function via signal transduction by binding to cell surface receptors and/or delivery of the luggage by phagocytosis, pinocytosis, and membrane fusion. Therefore, sEV are now recognized as the active particles mediating cell--to--cell communication \[[@r14], [@r24]\].

Recent studies suggest that sEV play a key role in various disease states, including cancer \[[@r7]\], neurodegenerative diseases \[[@r6]\], and cardiovascular diseases \[[@r22]\]. For example, it was reported that bladder cancer cell-derived sEV inhibited tumor cell apoptosis and induced cell proliferation, suggesting that tumor-derived sEV are involved in the progression of bladder cancer \[[@r25]\]. On the other hand, it was reported that non-cancerous cells-derived sEV suppressed the growth of cancer cell \[[@r9]\]. It has also been suggested that the infectious prion protein, a causative agent of prion disease, may be transmitted via sEV \[[@r21]\]. The sEV released by cardiomyocytes after the hypoxic stimulation contain angiotensin II (Ang II) type 1 receptor (AT1R). Then, the administration of this sEV into AT1R knockout mice restored the Ang II-dependent increase in systemic blood pressure (SBP) \[[@r18]\]. More recently, we demonstrated that plasma sEV in normotensive Wistar Kyoto rats (WKY) and spontaneously hypertensive rats (SHR), an animal model of human systemic hypertension (WsEV and SsEV, respectively), regulated SBP \[[@r17]\]. Further, it was recently reported that diabetic mice-derived large EV promoted the signaling pathway that caused the endothelial dysfunction \[[@r23]\]. An abnormal vascular reactivity is involved in the onset and progression of hypertension. In the present study, we then tested the hypothesis that sEV may affect the reactivity of isolated blood vessels. As a result, we revealed for the first time that SsEV specifically impaired the agonist-induced contractility of rat isolated mesenteric arteries.

MATERIALS AND METHODS {#s1}
=====================

Animals
-------

Animal care and procedures were done in conformity with the institutional guideline of School of Veterinary Medicine, the Kitasato University. This animal study was approved by the ethical committee of School of Veterinary Medicine, the Kitasato University. Male WKY, SHR (Hoshino Laboratory Animals, Inc., Bandou, Japan), and normal Wistar rats (CLEA Japan, Inc., Tokyo, Japan) were used. They can freely take food (CE2, CLEA Japan, Inc.) and tap water.

Measurement of body weight and SBP
----------------------------------

Body weight and SBP of WKY and SHR (8-week-old) were measured after the initial induction and before the use. SBP was measured by a tail cuff method using a non-invasive automatic blood pressure measurement device (BP-98AL; Softron, Tokyo, Japan). We confirmed that SHR exhibited hypertension compared with WKY.

sEV isolation from rat plasma
-----------------------------

sEV were isolated from plasma of WKY (WsEV) and SHR (SsEV) by the precipitation with polyethylene-glycol and ultracentrifugation as previously described \[[@r15], [@r16]\]. WKY and SHR (8-week-old) were deeply anesthetized with urethane (Sigma-Aldrich, St. Louis, MO, USA) (1.5 g/kg, i.p.). Blood was drawn via an inferior vena cava, gently mixed with heparin (1 U/m*l*), and centrifuged (room temperature; RT, 1,000 g, 10 min) in order to isolate plasma. The plasma samples were centrifuged (4°C, 10,000 g, 10 min) to remove large EV, and the supernatants was mixed with an equal volume of sterilized polyethylene-glycol solution by inverting (4°C, overnight). After centrifugation (4°C, 2,500 g, 15 min), the pellets were resuspended in sterilized phosphate-buffered saline (PBS) by vigorous vortex (RT, 30 min) and ultracentrifuged (4°C, 164,071 g, 35 min) by using an Optima XL-80K ultracentrifuge with a swing rotor SW 55 Ti (Beckman Coulter Inc., Miami, FL, USA). The pellets were resuspended in sterilized PBS and used for the following experiments.

Measurement of particle distribution and concentration of plasma sEV
--------------------------------------------------------------------

Particle distribution and concentration of the isolated sEV were measured by a tunable resistive pulse sensing (TRPS) method using a qNANO instrument with an NP150 nanopore at 46.5--47.5 mm stretch (IZON Science, Christchurch, New Zealand) according to the manufacturer's instruction as previously reported \[[@r15], [@r16]\].

Tissue preparation and organ culture procedure
----------------------------------------------

Normal male Wistar rats (6--8-week-old) were deeply anesthetized with urethane and euthanized by exsanguination. The main branch of the superior mesenteric artery was isolated under sterile conditions. After removal of fat and adventitia in sterilized Tris-buffered saline (TBS), the mesenteric artery was cut into rings (1-mm in diameter, 2-mm in length) for organ culture and subsequent measurement of isometric contraction. Arterial rings were then placed in 1 m*l* serum-free-Dulbecco's Modified Eagle Medium (DMEM) with WsEV, SsEV (8.0 × 10^8^ particles/m*l*), or vehicle (PBS) supplemented with 1% penicillin-streptomycin. They were maintained at 37°C in an atmosphere of 95% air and 5% CO~2~ for 24 hr \[[@r12], [@r13]\].

Measurement of isometric contraction
------------------------------------

The arterial rings were placed in normal physiological salt solution (PSS), which contained (mM): NaCl 139.9, KCl 5.4, CaCl~2~ 1.5, MgCl~2~ 1.0, NaHCO~3~ 23.8, and glucose 5.5 as reported previously \[[@r12], [@r13]\]. Ethylenediaminetetraacetic acid (EDTA), 10 *µ*M, was added to remove the contaminating heavy metal ions which catalyze oxidation of organic chemicals. High K^+^ (72.7 mM) solutions was prepared by replacing NaCl with equimolar KCl. These solutions were saturated with a 95% O~2~--5% CO~2~ mixture at 37°C and pH 7.4. Smooth muscle contraction was recorded isometrically with a force-displacement transducer (Nihon Kohden, Tokyo, Japan) after amplifying the signal with ISOMETRIC AMPLIFIER (EF-601G; Nihon Kohden). Each muscle ring was attached to a holder under a resting tension of 0.5 g. After equilibration for 30 min in a 3 m*l* organ bath, each ring was repeatedly exposed to high K^+^ (72.4 mM) solution until the responses became stable (45--60 min). Concentration-response curves for noradrenaline (NA) were obtained by the cumulative application of NA (0.1 nM--3 *µ*M).

Statistics analysis
-------------------

Data were presented as means ± standard error of the mean (SEM). In two-group comparison, statistical analyses were performed using an unpaired Student's *t*-test. In three-group comparison, statistical analyses were performed with a one- way ANOVA followed by Bonferroni's *post-hoc* test. To compare concentration-response curves, statistical analyses were performed with a two-way ANOVA followed by Bonferroni's *post hoc*-test. *P* values of less than 0.05 were considered statistically significant.

RESULTS {#s2}
=======

Particle distribution and concentration of plasma sEV from WKY and SHR
----------------------------------------------------------------------

We first compared the particle distribution and concentration between WsEV and SsEV. Both of them distributed within the expected size ranges with a diameter of \~100--150 nm, and did not differ as determined by the TRPS analyses ([Fig. 1a, 1b](#fig_001){ref-type="fig"}Fig. 1.Particle distribution and concentration of plasma small extracellular vesicles (sEV) from Wistar Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). The sEV were separated from heparin (1 U/m*l*)-treated plasma in male WKY (8-week-old) and SHR (8-week-old) by precipitation with polyethylene-glycol (8%, 12 hr) and ultracentrifugation (4°C, 164,071 g, 35 min). The particle distribution and concentration of sEV were measured with a tunable resistive pulse sensing analysis. Particle distribution and concentration of plasma sEV from WKY (a) and SHR (b) were shown. Results were expressed as means ± standard error of the mean (n=3)., n=3). We also confirmed that there was no significant difference in total concentration ([Table 1](#tbl_001){ref-type="table"}Table 1.Total concentration, mean diameter, and mode diameter of plasma small extracellular vesicles (sEV) from Wistar Kyoto rats and spontaneously hypertensive rats (WsEV and SsEV, respectively)WsEVSsEVTotal concentration (particles/m*l* plasma)7.8 ± 2.5 × 10^9^(n=3)6.3 ± 1.9 × 10^9^(n=3)Mean diameter (nm)125.3 ± 9.9(n=3)126.2 ± 5.5(n=3)Mode diameter (nm)98.0 ± 6.6(n=3)95.3 ± 1.2(n=3)Total concentration, mean diameter, and mode diameter of sEV were measured with a tunable resistive pulse sensing analysis. Results were expressed as means ± standard error of the mean., n=3), mean diameter ([Table 1](#tbl_001){ref-type="table"}, n=3), and mode (the most frequent) diameter ([Table 1](#tbl_001){ref-type="table"}, n=3).

Effects of long-term treatment with WsEV and SsEV on KCl-induced contractile response in rat isolated mesenteric arteries
-------------------------------------------------------------------------------------------------------------------------

We first examined the effects of pretreatment with sEV on KCl-induced maximal contraction in rat isolated mesenteric arteries. Pretreatment of mesenteric arteries with WsEV (8.0 × 10^8^ particles/m*l*, 24 hr) had no effect on the KCl (72.7 mM)-induced contraction compared with vehicle (PBS)-treatment ([Fig. 2](#fig_002){ref-type="fig"}Fig. 2.Effects of long-term (24 hr) treatment with plasma small extracellular vesicles from Wistar Kyoto rats (WsEV) or spontaneously hypertensive rats (SsEV) (8.0 × 10^8^ particles/m*l*) on KCl (72.7 mM)-induced contractile response in rat isolated mesenteric arteries. Contraction was expressed as an absolute value (g/mg tissue wet weight). Results were expressed as means ± standard error of the mean (n=10 \[phosphate-buffered saline (PBS)\], n=8 \[WsEV\], n=12 \[SsEV\])., WsEV, n=8 vs. PBS, n=10). Similarly, pretreatment of mesenteric arteries with SsEV (8.0 × 10^8^ particles/m*l*, 24 hr) had no significant effects on the KCl-induced contraction compared with vehicle- and WsEV-treatment ([Fig. 2](#fig_002){ref-type="fig"}, SsEV, n=12).

Effects of long-term treatment with WsEV or SsEV on NA-induced contractile response in rat isolated mesenteric arteries
-----------------------------------------------------------------------------------------------------------------------

We next examined the effects of pretreatment with sEV on NA (a sympathetic neurotransmitter)-induced contraction (relative contraction \[RC\] and absolute contraction \[AC\]) of rat isolated mesenteric arteries. Pretreatment of mesenteric arteries with WsEV (8.0 × 10^8^ particles/m*l*, 24 hr) had no effect on the NA (0.1 nM--3 *µ*M)-induced contraction (both RC and AC) compared with vehicle-treatment (Fig. 3ab, closed circle WsEV, n=8 vs. open circle PBS, n=10). On the other hand, pretreatment of mesenteric arteries with SsEV (8.0 × 10^8^ particles/m*l*, 24 hr) significantly attenuated the NA-induced contraction (both RC and AC) compared with vehicle- or WsEV-treatment (Fig. 3ab, closed triangle SsEV, n=11--12, *P*\<0.05 and 0.01 vs. open circle PBS or closed circle WsEV).

DISCUSSION {#s3}
==========

In the present study, we examined the effects of long-term treatment with WsEV or SsEV (24 hr) on the reactivity of rat isolated mesenteric arteries. The major findings are as follows: 1) There was no significant difference in total concentration, mean diameter, and mode diameter between WsEV and SsEV ([Fig. 1](#fig_001){ref-type="fig"}, [Table 1](#tbl_001){ref-type="table"}). 2) WsEV and SsEV had no significant effect on the KCl (72.7 mM)-induced maximal contraction ([Fig. 2](#fig_002){ref-type="fig"}). 3) WsEV had no effect on the NA (0.1 nM-3 *µ*M)-induced contraction (RC and AC). On the other hand, SsEV significantly attenuated the NA (0.1 nM--3 *µ*M)-induced contraction (RC and AC) ([Fig. 3](#fig_003){ref-type="fig"}Fig. 3.Concentration-contraction relationship for noradrenaline (NA) in rat isolated mesenteric arteries cultured with plasma small extracellular vesicles from Wistar Kyoto rats (WsEV) or spontaneously hypertensive rats (SsEV) (8.0 × 10^8^ particles/m*l*) for 24 hr. NA (0.1 nM−3 *µ*M) was cumulatively applied. Contraction was normalized to the maximal contraction induced by KCl (72.7 mM) (a) or expressed as an absolute value (b: g/mg tissue wet weight). Results were expressed as means ± standard error of the mean (a: n=10 \[phosphate-buffered saline (PBS)\], n=8 \[WsEV\], n=12 \[SsEV\], b: n=10 \[PBS\], n=8 \[WsEV\], n=11 \[SsEV\]). \*\**P*\<0.01 vs. PBS, \#*P*\<0.05 and \#\#*P*\<0.01 vs. WsEV.). From the above results, it was for the first time revealed that long-term treatment with SsEV specifically impaired the agonist-induced contractility of isolated blood vessels. It is known that vascular smooth muscle cell (VSMC) undergoes phenotypic conversion from a contractile to a synthetic state during the cardiovascular diseases including hypertension. Therefore, it is proposed that SsEV may be at least in part responsible for VSMC phenotypic conversion.

In the present study, it was found that total concentration and size distribution in plasma sEV derived from hypertensive rats did not change compared with normotensive rats ([Fig. 1](#fig_001){ref-type="fig"}, [Table 1](#tbl_001){ref-type="table"}). It was recently reported that the molecular cargoes changed in various disease states without changes in concentration and size distribution of sEV. For example, metabolic syndrome modulated the profiles of mRNA cargo packed within sEV derived from mesenchymal stem cells of porcine adipose tissue \[[@r10]\]. In addition, AT1R-enriched sEV were released by the cardiomyocytes after hypoxic stimulation \[[@r18]\]. From the above reports, it is proposed that the molecular cargoes in plasma sEV from animal models of essential hypertension could change, which needs to be further explored in the future study.

In the present study, we treated the isolated mesenteric arteries with sEV at 8.0 × 10^8^ particles/m*l* ([Figs. 2](#fig_002){ref-type="fig"} and[3](#fig_003){ref-type="fig"}). It was reported that the concentration of plasma sEV in rats was approximately 10^8^--10^12^ particles/m*l* \[[@r4], [@r5], [@r11]\]. In addition, previous investigations used EV at wide-ranging concentrations between 10^5^--10^10^ particles/m*l* \[[@r1], [@r3]\]. Based on the above reports, the concentration of sEV used in the present study would be appropriate. In addition, we treated the isolated mesenteric arteries with sEV for 24 hr ([Figs. 2](#fig_002){ref-type="fig"} and[3](#fig_003){ref-type="fig"}). It remains to be clarified whether sEV are stable in circulation for 24 hr. We previously confirmed that sEV were uptaken into VSMC within 2 hr \[[@r16]\] and that they were remaining within the cells after 24 hr. Since we focused on the effects of small RNA including microRNA in sEV, which mediates the protein expression in the recipient cells, we examined the long-term effects of sEV. On the other hand, we also need to examine the short-term effects of sEV, since proteins contained in sEV are transferrable within a short period of time.

In the present study, it was found that the long-term treatment of rat isolated mesenteric arteries with SsEV specifically attenuated the NA-induced contraction (RC and AC) without affecting the KCl (72.7 mM)-induced maximal contraction ([Figs. 2](#fig_002){ref-type="fig"} and[3](#fig_003){ref-type="fig"}). The mechanism of VSMC contraction by high K^+^ is based on the activation of contractile protein \[phosphorylation of myosin light chain (MLC)\] by extracellular Ca^2+^ influx through the opening of voltage-dependent Ca^2+^ channels by membrane depolarization. On the other hand, NA-induced VSMC contraction is mediated not only through the extracellular Ca^2+^ influx but also through the inositol trisphosphate (IP~3~)-dependent Ca^2+^ release from sarcoplasmic reticulum via the activation of α~1~ adrenergic receptor-G~q~ protein. Therefore, it is suggested that the inhibition of α~1~ adrenergic receptor-G~q~ protein-IP~3~-Ca^2+^ release pathway is at least partly responsible for the impaired NA-induced VSMC contraction by SsEV.

In conclusion, it was for the first time revealed that SsEV specifically impair the agonist-induced contractility of isolated blood vessels, which might be at least partly responsible for the blood pressure regulation by SsEV. Further researches are required to elucidate the underlying mechanisms of plasma sEV regulation of etiology of systemic hypertension.
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